Sleep medicine guidelines for managing restless legs syndrome and periodic limb movements: a plain language summary

This Plain Language Summary of Publication article (PLSP) from Expert Review of Neurotherapeutics describes how the American Academy of Sleep Medicine (AASM) updated its clinical practice guidelines for treating restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). The original 2012 guidelines recommended dopamine agonists based on the understanding that genetics and abnormal iron and dopamine levels caused these conditions. However, after reviewing a decade of clinical evidence, the AASM discovered that while dopamine agonists provided short-term relief, they often worsened symptoms over time.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline’ and was published in the Journal of Clinical Sleep Medicine.

Visit JCSM using the link to read the original article.

• Alpha-2-delta ligand
• Augmentation
• Clinical Practice Guidelines
• Dopamine agonist
• Iron
• Periodic Limb Movement Disorder
• plain language summary
• Restless Legs Syndrome
• Sleep-related Movement Disorders
• Willis-Ekbom disease